FRONTIER CAPITAL MANAGEMENT CO LLC – Karyopharm Therapeutics Inc. Transaction History
FRONTIER CAPITAL MANAGEMENT CO LLC portfolio value:
$3.43M
portfolio value
FRONTIER CAPITAL MANAGEMENT CO LLC quarter portfolio value change:
+21.06%
quarter
Karyopharm Therapeutics Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.53% | -3.35K shares | 582K | $5.46 | 629.15K |
| Q2 2022 | share | Decrease | -50.56% | -646.78K shares | -6.57M | $4.51 | 632.50K |
| Q1 2022 | share | Decrease | -24.10% | -406.11K shares | -1.40M | $7.37 | 1.27M |
| Q4 2021 | share | Increase | +52.88% | 582.97K shares | 4.42M | $6.72 | 1.68M |
| Q3 2021 | share | Decrease | -25.96% | -386.51K shares | -8.95M | $5.82 | 1.10M |
| Q2 2021 | share | Increase | +21.88% | 267.31K shares | 2.51M | $10.32 | 1.48M |
| Q1 2021 | share | Decrease | -60.94% | -1.90M shares | -35.56M | $10.52 | 1.22M |
| Q4 2020 | share | Decrease | -15.56% | -576.21K shares | -5.66M | $15.48 | 3.12M |
| Q3 2020 | share | Increase | +32.73% | 913.28K shares | 1.22M | $14.6 | 3.70M |
| Q2 2020 | share | Increase | +51.70% | 951.06K shares | 17.51M | $18.94 | 2.79M |
| Q1 2020 | share | Increase | +80.49% | 820.30K shares | 15.79M | $19.21 | 1.83M |
| Q4 2019 | share | Decrease | -42.61% | -756.72K shares | 2.45M | $19.17 | 1.01M |
| Q3 2019 | share | Increase | +160.07% | 1.09M shares | 12.99M | $9.62 | 1.77M |
| Q2 2019 | share | Decrease | -0.07% | -510 shares | 99K | $5.99 | 682.85K |
| Q1 2019 | share | Increase | +311.92% | 517.46K shares | 2.43M | $5.84 | 683.36K |
| Q4 2018 | share | Decrease | -18.90% | -38.65K shares | -1.93M | $9.37 | 165.89K |
| Q3 2018 | share | Decrease | -33.38% | -102.47K shares | -1.73M | $17.03 | 204.55K |
| Q2 2018 | share | Increase | 0.00% | 307.03K shares | 5.21M | $16.99 | 307.03K |